Azadirachtin

DB19419InvestigationalSmall molecule

Azadirachtin is under investigation in clinical trial NCT06617026 (Short-term Outcome of Medical vs. Surgical Management of Chronic Anal Fissure).

Mechanism: Pharmacologically active on Acetylcholinesterase
Curator reviewed
Formula / weight: C₃₅H₄₄O₁₆ · 720.721 g/mol (avg)
Also known as: Azadirachtin a · Azatin · Biosal · Ecozin · Gronim
Code names: NSC-368675 · OIKOS

Resolves to

Compound

UNIIO4U1SAF85HCAS11141-17-6ChEMBLCHEMBL509309ChEBI2942KEGGC08748

Clinical / RWD

RxNorm18586

Structure

InChIKeyFTNJWQUOZFUQQJ-NDAWSKJSSA-NSMILES

[H][C@@]12OC=C[C@]1(O)[C@@H]1C[C@H](O2)[C@]2(O[C@@]12C)[C@]1(C)[C@H](O)[C@]2([H])OC[C@@]3([C@@H](C[C@H](OC(=O)C(\C)=C\C)[C@@]4(CO[C@](O)(C(=O)OC)[C@@]14[H])[C@@]23[H])OC(C)=O)C(=O)OC

Targets

P22303ACHE

What you can answer from here — as of September 21, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Azadirachtin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account